Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate in adults with severe atopic dermatitis
2005-000871-16Phase 4Unknown
- Sponsor
- Dr John Berth-Jones
- Start
- Feb 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in atopic dermatitis (AD) comparing methotrexate with placebo (2 arms). Primary endpoint: Primary efficacy: Six Area, Six Sign Atopic Dermatitis score. Status: unknown.
02
Drugs
methotrexate
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2005-000871-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000871-16.